Chinese medicine maker addresses global TCM gathering, bringing flagship heart pill to trial in Singapore

Singapore, October 19, 2026 -- Famous Chinese medicine maker told a global gathering of traditional Chinese medicine (TCM) practitioners here Saturday that a 500-year-old tradition built on treating the whole patient and tailoring treatment has offered an Eastern answer to aging societies and chronic disease worldwide.

According to a press report issued by China News Service (CNS) , Tianjin Pharmaceutical Da Ren Tang Group, one of China's oldest pharmacy houses, also announced it will bring an international randomized, double-blind, controlled trial of its flagship heart remedy, sold in English as Suxiao Jiuxin Pills, with Singapore General Hospital, the city-state's largest acute tertiary hospital.

Wang Lei, chairman of Da Ren Tang and president of Tianjin Pharmaceutical Group, made both points in her address to the opening ceremony of the 23rd World Congress of Chinese Medicine in Singapore, noting the Chinese medicine's holistic approach and pattern-based diagnosis give it an advantage in strengthening public health systems, and the industry must prove as much through internationally recognized, verifiable evidence, the CNS report said.

(Wang Lei, chairman of Da Ren Tang and president of Tianjin Pharmaceutical Group, addresses the congress)

The study is the first time a Chinese proprietary medicine has been put through clinical trials at a major Western-medicine hospital in Singapore, the CNS report highlighted.

"We have always believed that Chinese medicine cannot stop at product exports," Wang said, adding that the trial would offer clinical evidence that would be internationally recognized and verified.

According the CNS report, the company is working with Singapore General Hospital on the study and hopes solid results will help traditional medicine enter national health systems and reach more patients overseas.

Wang called on the congress to bring Chinese medicine standards in line with international rules, to build platforms that share research results, and to tell the story of Chinese medicine to the world.

Da Ren Tang traces its pharmacy lineage to 1522 and has been listed in Singapore since 1997. The company holds 122 exclusive products and 599 drug approval numbers, sells more than 150 products in more than 20 countries and ranks among China's top five exporters of traditional Chinese medicine, said the CNS report.

Contact Info:
Name: Ms. Yujiao Li
Email: Send Email
Organization: China News Service
Website: https://www.chinanews.com.cn/jk/2026/10-17/10716422.shtml

Release ID: 89206602

In case of identifying any errors, concerns, or inconsistencies within the content shared in this press release that necessitate action or if you require assistance with a press release takedown, we strongly urge you to notify us promptly by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our expert team is committed to addressing your concerns within 8 hours by taking necessary actions diligently to rectify any identified issues or supporting you with the removal process. Delivering accurate and reliable information remains our top priority.